IL10 and cancer: Results showed that IL–10 overexpression was associated with worse 1-year DFS (OR = 3.34, 95% CI = 1.40 to 7.94, P = 0.0006) and worse 2-year DFS (OR = 3.91, 95% CI = 1.79 to 8.53, P = 0.0006) of cancer.